A detailed history of Financial Freedom, LLC transactions in Organon & Co. stock. As of the latest transaction made, Financial Freedom, LLC holds 199 shares of OGN stock, worth $4,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199
Previous 198 0.51%
Holding current value
$4,007
Previous $2.85 Million 30.95%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$13.78 - $18.8 $13 - $18
1 Added 0.51%
199 $3.74 Million
Q4 2023

Jan 24, 2024

SELL
$10.95 - $17.32 $766 - $1,212
-70 Reduced 26.12%
198 $2.85 Million
Q3 2023

Nov 03, 2023

BUY
$16.59 - $23.77 $33 - $47
2 Added 0.75%
268 $4.65 Million
Q2 2023

Jul 28, 2023

BUY
$19.27 - $24.63 $38 - $49
2 Added 0.76%
266 $5.54 Million
Q1 2023

May 01, 2023

BUY
$21.42 - $32.08 $21 - $32
1 Added 0.38%
264 $6.22 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $6,130 - $7,524
263 New
263 $7.34 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.12B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Financial Freedom, LLC Portfolio

Follow Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Freedom, LLC with notifications on news.